News & Insights from IRC Partners

IRC Partners publishes institutional-grade research on capital stack structuring, GP/LP economics, debt and equity positioning, fund formation, and LP due diligence for real estate developers and growth-stage founders raising
$5M to $250M.
Each article is written to the standard institutional investors use to evaluate sponsors, not as general education.

Drag-along rights and how they can block a Series B exit or recap.
Samuel Levitz
April 23, 2026

Drag-Along Rights Gone Wrong: The Clause That Lets Minority Investors Block Your Series B Exit or Recap

A defective drag-along clause gives minority holders veto power over your Series B or exit. The leverage is procedural, not proportional to ownership.
The hidden cost of uncapped MFN SAFEs at Series B.
Samuel Levitz
April 22, 2026

The Hidden Cost of Uncapped MFN SAFEs: How Most-Favored-Nation Clauses Silently Reprice Your Entire Seed Round at Series B

Seed terms don't expire at close. Participating preferred, full ratchet anti-dilution, and aggressive pro-rata rights compound into Series B problems.
The long-term cost of seed round terms at Series B.
Samuel Levitz
April 22, 2026

That Seed Round Term Looked Fine. It's Now Costing You $8M at Series B

The option pool shuffle expands your equity pool before pricing. Founders absorb 100% of that dilution. The incoming investor absorbs none.
Explanation of the option pool shuffle and pre-money valuation dilution.
Samuel Levitz
April 22, 2026

Option Pool Shuffle Explained: How Investors Use Your Pre-Money Valuation to Quietly Dilute You Before the Round Closes

Series B investors model your option pool before your revenue. It reveals hidden dilution, hiring capacity, and whether your cap table is clean.
Series B investor focus on option pools versus revenue.
Samuel Levitz
April 22, 2026

Your Series B Investor Is Looking at Your Option Pool Before They Look at Your Revenue

Series B investors model your option pool before your revenue. It reveals hidden dilution, hiring capacity, and whether your cap table is clean.
Samuel Levitz
April 21, 2026

What Cap Table Issues Will Kill a Series B Before the Lead Investor Even Reads Your Deck

Cap table defects kill a Series B before the deck is read. Stacked SAFEs, consent rights, and missing docs are screened before your revenue.
The risk of multiple SAFEs converting at Series B.
Samuel Levitz
April 21, 2026

You Raised Three SAFEs. Here's How They're About to Detonate at Your Series B

Three stacked post-money SAFEs can consume 25-40% of your Series B cap table before it is priced. Most founders never model it until too late.
How SAFE and convertible notes impact a Series B cap table.
Samuel Levitz
April 21, 2026

How SAFE Notes and Convertible Notes Stack Up and Silently Destroy Your Series B Cap Table

Uncapped convertible notes have no valuation ceiling. At Series B, that means dilution the founder cannot predict until the round price is set.
The convertible note overhang problem and Series B red flags.
Samuel Levitz
April 21, 2026

The Convertible Note Overhang Problem: Why Uncapped Notes From Your Seed Round Are a Series B Red Flag

Uncapped convertible notes have no valuation ceiling. At Series B, that means dilution the founder cannot predict until the round price is set.

Schedule A Meeting

You get one shot to raise the right way. If this raise is worth doing, it’s worth doing with precision, leverage, and control.
This isn’t a practice run. Serious capital. Serious strategy. Let’s raise it right.

We onboard a maximum of 7
new strategic partners each quarter, by application only, to maximize your chances of securing the capital you need.